,address1,address2,city,zip,country,phone,website,industry,sector,longBusinessSummary,fullTimeEmployees,companyOfficers,maxAge,priceHint,previousClose,open,dayLow,dayHigh,regularMarketPreviousClose,regularMarketOpen,regularMarketDayLow,regularMarketDayHigh,payoutRatio,beta,volume,regularMarketVolume,averageVolume,averageVolume10days,averageDailyVolume10Day,bid,ask,marketCap,fiftyTwoWeekLow,fiftyTwoWeekHigh,fiftyDayAverage,twoHundredDayAverage,trailingAnnualDividendRate,trailingAnnualDividendYield,currency,enterpriseValue,profitMargins,floatShares,sharesOutstanding,heldPercentInsiders,heldPercentInstitutions,lastFiscalYearEnd,nextFiscalYearEnd,mostRecentQuarter,trailingEps,exchange,quoteType,symbol,underlyingSymbol,shortName,longName,firstTradeDateEpochUtc,timeZoneFullName,timeZoneShortName,gmtOffSetMilliseconds,currentPrice,recommendationKey,quickRatio,currentRatio,returnOnAssets,returnOnEquity,grossMargins,ebitdaMargins,operatingMargins,financialCurrency,trailingPegRatio
0,Karolinska Institutet Science Park,Fogdevreten 2,Solna,171 65,Sweden,46 8 52 48 44 82,https://www.asarinapharma.com,Biotechnology,Healthcare,"Asarina Pharma AB (publ), a biotech company, researches and develops pharmaceutical products. Its flagship product is Sepranolone, which is used for the treatment of menstrual migraine and Tourette syndrome. The company was formerly known as Umecrine Mood AB and changed its name to Asarina Pharma AB (publ) in 2016. The company was incorporated in 2005 and is based in Solna, Sweden.",1,"{'maxAge': 1, 'name': 'Mr. Peter  Nordkild M.D.', 'age': 67, 'title': 'CEO & Chief Medical Officer', 'yearBorn': 1955, 'exercisedValue': 0, 'unexercisedValue': 0}",86400,4,0.054,0.0542,0.0542,0.0542,0.054,0.0542,0.0542,0.0542,0.0,0.283604,300,300,4,0,0,0.054,0.0942,1674780,0.047,0.3,0.064832,0.09083,0.0,0.0,EUR,1227164,0.0,16192909,22641400,0.38277,0.31915,1672444800,1703980800,1688083200,-0.05,FRA,EQUITY,APS.F,APS.F,ASARINA PHARMA AB,Asarina Pharma AB (publ),1596434400,Europe/Berlin,CEST,7200000,0.0542,none,2.695,2.773,-0.69556,-1.1766,0.0,0.0,0.0,SEK,
1,Karolinska Institutet Science Park,Fogdevreten 2,Solna,171 65,Sweden,46 8 52 48 44 82,https://www.asarinapharma.com,Biotechnology,Healthcare,"Asarina Pharma AB (publ), a biotech company, researches and develops pharmaceutical products. Its flagship product is Sepranolone, which is used for the treatment of menstrual migraine and Tourette syndrome. The company was formerly known as Umecrine Mood AB and changed its name to Asarina Pharma AB (publ) in 2016. The company was incorporated in 2005 and is based in Solna, Sweden.",1,"{'maxAge': 1, 'name': 'Mr. Jakob Dynnes Hansen M.Sc., MBA', 'age': 67, 'title': 'Chief Financial Officer', 'yearBorn': 1955, 'exercisedValue': 0, 'unexercisedValue': 0}",86400,4,0.054,0.0542,0.0542,0.0542,0.054,0.0542,0.0542,0.0542,0.0,0.283604,300,300,4,0,0,0.054,0.0942,1674780,0.047,0.3,0.064832,0.09083,0.0,0.0,EUR,1227164,0.0,16192909,22641400,0.38277,0.31915,1672444800,1703980800,1688083200,-0.05,FRA,EQUITY,APS.F,APS.F,ASARINA PHARMA AB,Asarina Pharma AB (publ),1596434400,Europe/Berlin,CEST,7200000,0.0542,none,2.695,2.773,-0.69556,-1.1766,0.0,0.0,0.0,SEK,
2,Karolinska Institutet Science Park,Fogdevreten 2,Solna,171 65,Sweden,46 8 52 48 44 82,https://www.asarinapharma.com,Biotechnology,Healthcare,"Asarina Pharma AB (publ), a biotech company, researches and develops pharmaceutical products. Its flagship product is Sepranolone, which is used for the treatment of menstrual migraine and Tourette syndrome. The company was formerly known as Umecrine Mood AB and changed its name to Asarina Pharma AB (publ) in 2016. The company was incorporated in 2005 and is based in Solna, Sweden.",1,"{'maxAge': 1, 'name': 'Mr. Torbjörn  Bäckström M.D., Ph.D.', 'age': 74, 'title': 'Chief Science Officer & Chairman of Scientific Advisory Board', 'yearBorn': 1948, 'exercisedValue': 0, 'unexercisedValue': 0}",86400,4,0.054,0.0542,0.0542,0.0542,0.054,0.0542,0.0542,0.0542,0.0,0.283604,300,300,4,0,0,0.054,0.0942,1674780,0.047,0.3,0.064832,0.09083,0.0,0.0,EUR,1227164,0.0,16192909,22641400,0.38277,0.31915,1672444800,1703980800,1688083200,-0.05,FRA,EQUITY,APS.F,APS.F,ASARINA PHARMA AB,Asarina Pharma AB (publ),1596434400,Europe/Berlin,CEST,7200000,0.0542,none,2.695,2.773,-0.69556,-1.1766,0.0,0.0,0.0,SEK,
3,Karolinska Institutet Science Park,Fogdevreten 2,Solna,171 65,Sweden,46 8 52 48 44 82,https://www.asarinapharma.com,Biotechnology,Healthcare,"Asarina Pharma AB (publ), a biotech company, researches and develops pharmaceutical products. Its flagship product is Sepranolone, which is used for the treatment of menstrual migraine and Tourette syndrome. The company was formerly known as Umecrine Mood AB and changed its name to Asarina Pharma AB (publ) in 2016. The company was incorporated in 2005 and is based in Solna, Sweden.",1,"{'maxAge': 1, 'name': 'Mark  DuBois', 'title': 'Communications Mang.', 'exercisedValue': 0, 'unexercisedValue': 0}",86400,4,0.054,0.0542,0.0542,0.0542,0.054,0.0542,0.0542,0.0542,0.0,0.283604,300,300,4,0,0,0.054,0.0942,1674780,0.047,0.3,0.064832,0.09083,0.0,0.0,EUR,1227164,0.0,16192909,22641400,0.38277,0.31915,1672444800,1703980800,1688083200,-0.05,FRA,EQUITY,APS.F,APS.F,ASARINA PHARMA AB,Asarina Pharma AB (publ),1596434400,Europe/Berlin,CEST,7200000,0.0542,none,2.695,2.773,-0.69556,-1.1766,0.0,0.0,0.0,SEK,
4,Karolinska Institutet Science Park,Fogdevreten 2,Solna,171 65,Sweden,46 8 52 48 44 82,https://www.asarinapharma.com,Biotechnology,Healthcare,"Asarina Pharma AB (publ), a biotech company, researches and develops pharmaceutical products. Its flagship product is Sepranolone, which is used for the treatment of menstrual migraine and Tourette syndrome. The company was formerly known as Umecrine Mood AB and changed its name to Asarina Pharma AB (publ) in 2016. The company was incorporated in 2005 and is based in Solna, Sweden.",1,"{'maxAge': 1, 'name': 'Mr. Otto  Skolling M.Sc', 'age': 61, 'title': 'Chief Bus. Officer', 'yearBorn': 1961, 'exercisedValue': 0, 'unexercisedValue': 0}",86400,4,0.054,0.0542,0.0542,0.0542,0.054,0.0542,0.0542,0.0542,0.0,0.283604,300,300,4,0,0,0.054,0.0942,1674780,0.047,0.3,0.064832,0.09083,0.0,0.0,EUR,1227164,0.0,16192909,22641400,0.38277,0.31915,1672444800,1703980800,1688083200,-0.05,FRA,EQUITY,APS.F,APS.F,ASARINA PHARMA AB,Asarina Pharma AB (publ),1596434400,Europe/Berlin,CEST,7200000,0.0542,none,2.695,2.773,-0.69556,-1.1766,0.0,0.0,0.0,SEK,
